Home
Search
Search Results
Previously Searched
3114 results found
Expand All
Apply All
3114 results found

340B profits often exceed charity care spending
Good Day BIO Newsletter  •  March 28, 2024
A new study finds that hospitals serving some of the most vulnerable patients earn more in 340B profit than they spend on charity care—another sign of the need for 340B reform. Plus—get ready for extra-nutritious purple tomatoes. (582 words, 2 minutes, 54 seconds)
Read More

Programs & Initatives

What's next for COVID vaccines?
Good Day BIO Newsletter  •  March 27, 2024
Moderna announced exciting updates in its vaccine pipeline, and a recent USDA report explains how biomass can help us build a stronger bioeconomy. (616 words, 3 minutes, 4 seconds)
Read More

Biotech benefits pets (and their people)
Good Day BIO Newsletter  •  March 26, 2024
Today’s new episode of the I am BIO Podcast explores how we’re unleashing biotech to support our furry friends—and The Autoimmune Association shares five things you should know about autoimmune disease. (516 words, 2 minutes, 34 seconds)
Read More

Biotech for our Pets
I am BIO Podcast  •  March 26, 2024
More than half of U.S. households include pets, but there has been a lack of medical treatments developed specifically for small animals. Biotech companies are working to change that with new treatment options that both borrow from and, potentially, advance human health discoveries.
Read More
podcast

Heart disease patients and IRA’s misguided incentives
Good Day BIO Newsletter  •  March 25, 2024
BIO explains why the Inflation Reduction Act (IRA) price controls will lead to fewer cardiovascular treatments, and how we can achieve the government’s “Bold Goals” for the bioeconomy. (482 words, 2 minutes, 24 seconds)
Read More

Experts call for VICP updates to bolster vaccine confidence
Good Day BIO Newsletter  •  March 22, 2024
We recap yesterday’s hearing on the Vaccine Injury Compensation Program (and BIO’s take on reform). Plus, it’s World Water Day—and we look at how biotech can address contamination and demand. (553 words, 2 minutes, 45 seconds)
Read More

Lawmakers urge action on AMR
Good Day BIO Newsletter  •  March 21, 2024
Lawmakers and HHS Secretary Xavier Becerra call for action on AMR—and BIO President and CEO John F. Crowley calls for a focus on building America’s biomanufacturing sector. (647 words, 3 minutes, 14 seconds)
Read More

Colorado PDAB could limit patient access to medicines
Good Day BIO Newsletter  •  March 20, 2024
We take a deep dive into what’s happening with Colorado’s Prescription Drug Affordability Board (PDAB) and explain why the early cherry blossoms are nothing to cheer (and what biotech could do about it). (501 words, 2 minutes, 30 seconds)
Read More

Pre-Clinical Safety (BioSafe) Committee Meeting
March 19, 2024
The BioSafe General Membership serves as a resource for BIO members and BIO staff by identifying and responding to key scientific and world-wide regulatory issues related to the preclinical safety evaluation of biopharmaceutical products on an as needed basis. General Members can participate in various expert working groups, task forces and work streams related to the preclinical safety of biologics.  For more information and to join the Committee, please contact Surea Gainey (sgainey@bio.org).
Read More